Qiang Tingting, Li Yiping, Xu Xiaowen, Lin Wenyong, Wang Xiaolong
Cardiovascular Research Institute of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai, China.
Cardiovascular Department of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai, China.
Am J Transl Res. 2020 Jul 15;12(7):3182-3197. eCollection 2020.
The incidence and mortality of coronary heart disease (CHD) continue to increase every year in China. It has become a serious public health concern, threatening people's health. The combination of herbs and drugs has become a common mode of treatment for various chronic diseases such as CHD and chronic lung disease. Clinical studies have shown that the combination of herbs and drugs can bring more clinical benefits in the treatment of CHD. However, safety issues caused by the interaction between herbs and drugs deserve attention. Recent findings indicate that many herbs and their active ingredients can affect the activities of cytochrome P450 enzyme system (CYP450s) and transporters related to drug metabolism, thus changing the metabolic process of combined drugs, leading to an increase or a decrease in plasma drug concentrations, finally increasing the uncertainty of clinical efficacy and the possibility of adverse events. This review aimed to discuss in detail the effect of herbs on CYP450s and/or transporters in the treatment of CHD and the potential herb-drugs interaction, thus providing the basis for the clinical rational combination of drugs.
在中国,冠心病(CHD)的发病率和死亡率每年都在持续上升。它已成为一个严重的公共卫生问题,威胁着人们的健康。草药与药物联合使用已成为冠心病和慢性肺病等各种慢性病的常见治疗方式。临床研究表明,草药与药物联合使用在冠心病治疗中能带来更多临床益处。然而,草药与药物相互作用引起的安全问题值得关注。最近的研究结果表明,许多草药及其活性成分会影响细胞色素P450酶系统(CYP450s)的活性以及与药物代谢相关的转运蛋白,从而改变联合用药的代谢过程,导致血浆药物浓度升高或降低,最终增加临床疗效的不确定性和不良事件发生的可能性。本综述旨在详细探讨草药在冠心病治疗中对CYP450s和/或转运蛋白的影响以及潜在的草药 - 药物相互作用,从而为临床合理联合用药提供依据。